US FDA staff ... over the therapy's benefits and risks by the U.S. Food and Drug Administration's advisory panel on Tuesday, ...
Lorbrena, like Pfizer's Xalkori, is designed to treat cancer with a mutation of a specific gene called anaplastic ... China's ...
The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, including one that is the first treatment in the United States based on the Nobel ...